Oracea (40mg doxycycline)

Oracea is a once per day 40mg (30mg immediate release and 10mg delayed release) doxycycline treatment for the papules and pustles of rosacea. Galderma promote Oracea as superior to 50mg a day of generic doxycycline because Oracea is a low enough dose to be promoted as an `anti-inflamatory only’ treatment and not suffering from potential problems of higher doses of antibiotics.

Be sure to checkout the Oracea User Reviews.

Recent Rosacea Blog Posts

Oracea launches as Apprilon in Canada

A press release today from Galderma confirms that they will be marketing the product known in the US as Oracea under the name Apprilon in Canada. All of the same precautions and prescription details for Apprilon are the same as for Oracea, i.e. it is the exact same modified-release capsule, 40 mg doxycycline. First of […]

Continue Reading

Oracea available as Efracea (now Apprilon) in Canada

This seems to have gone mostly unnoticed by rosacea sufferers, but in early 2012 Health Canada approved Efracea as a treatment for the papules and pustules of rosacea. Called a Summary Basis of Decision for Efracea, Health Canada decreed: Summary Basis of Decision (SBD) for EFRACEA EFRACEA Doxycycline monohydrate, 40 mg capsule Galderma Canada Inc. […]

Continue Reading

How much does Galderma earn each year from Oracea sales ? Well the actual amount is not published, but in September 2011 court proceedings we learnt that Mylan Pharmaceuticals projected sales of $260m in 2011 for Oracea. The parent company of Galderma, L’Oreal does not publish Oracea sales figures, so this press release is as […]

Continue Reading

Oracea is Not an Antibiotic, Apparently

This claim from the Oracea web site caught my eye. Oracea is NOT an antibiotic. A bit of poetic marketing license perhaps? Oracea is a 40mg dose of the antibiotic doxycycline, which is a member of the tetracycline family. 30mg of the dose of doxycycline is immediate release, and 10 mg is locked inside a […]

Continue Reading

Amneal Pharmaceuticals joins the Generic Oracea War

News today of yet another company in the courts fighting against Galderma for the right to make Generic Oracea. Amneal Pharmaceuticals, based in Gujarat, India, a producer of generic pharmaceuticals, has submitted an Abbreviated New Drug Application to the FDA. By doing so, Amneal Pharmaecuticals are seeking permission to market delayed release doxycycline 40mg for […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.